Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety (Q34869621)

5 August 2017

Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety (English)

1 reference

cognitive behavioral therapy

5 August 2017

0 references

1 reference

1 reference

4

Boris Birmaher

1 reference

5 August 2017

John T Walkup

1

1 reference

5 August 2017

Anne Marie Albano

2

1 reference

5 August 2017

John Piacentini

3

1 reference

5 August 2017

Scott N Compton

5

1 reference

5 August 2017

Joel T Sherrill

6

1 reference

5 August 2017

Golda S Ginsburg

7

1 reference

5 August 2017

Moira A Rynn

8

1 reference

5 August 2017

James McCracken

9

1 reference

5 August 2017

Bruce Waslick

10

1 reference

5 August 2017

Satish Iyengar

11

1 reference

5 August 2017

John S March

12

1 reference

5 August 2017

Philip C Kendall

13

1 reference

5 August 2017

language of work or name

English

0 references

publication date

30 October 2008

1 reference

5 August 2017

14

1 reference

The New England Journal of Medicine

inferred from page(s)

published in

1 reference

5 August 2017

359

1 reference

5 August 2017

2753-2766

1 reference

5 August 2017

26

1 reference

Evidence-based psychosocial treatments for phobic and anxiety disorders in children and adolescents

5 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702984

SET-C versus fluoxetine in the treatment of childhood social phobia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702984

Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702984

Cognitive behavioural therapy for anxiety disorders in children and adolescents

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702984

Defining empirically supported therapies

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702984

Therapy for youths with anxiety disorders: a second randomized clinical trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702984

Discriminating depression and anxiety in youth: a role for diagnostic criteria.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702984

A children's global assessment scale (CGAS)

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702984

Flexibility within fidelity.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702984

Cognitive-behavioral therapy for anxiety disordered youth: a randomized clinical trial evaluating child and family modalities

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702984

A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702984

Fluoxetine for the treatment of childhood anxiety disorders

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702984

Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702984

Six-year predictors of problems in a national sample of children and youth: I. Cross-informant syndromes.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702984

Psychopathology from adolescence into young adulthood: an 8-year follow-up study.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702984

Fluvoxamine for the Treatment of Anxiety Disorders in Children and Adolescents

26 October 2018

1 reference

12 December 2020

A Randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder

1 reference

12 December 2020

Pharmacologic treatment for children and adolescents with anxiety disorders

1 reference

12 December 2020

The Pediatric Anxiety Rating Scale (PARS): development and psychometric properties

1 reference

12 December 2020

Child-adult anxiety disorders

1 reference

12 December 2020

Treating anxiety disorders in children: results of a randomized clinical trial

1 reference

12 December 2020

The NIMH Diagnostic Interview Schedule for Children Version 2.3 (DISC-2.3): description, acceptability, prevalence rates, and performance in the MECA Study. Methods for the Epidemiology of Child and Adolescent Mental Disorders Study

1 reference

12 December 2020

Identifiers

DOI

10.1056/NEJMOA0804633

1 reference

5 August 2017

1 reference

5 August 2017

1 reference